IL158998A0 - Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines - Google Patents

Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines

Info

Publication number
IL158998A0
IL158998A0 IL15899802A IL15899802A IL158998A0 IL 158998 A0 IL158998 A0 IL 158998A0 IL 15899802 A IL15899802 A IL 15899802A IL 15899802 A IL15899802 A IL 15899802A IL 158998 A0 IL158998 A0 IL 158998A0
Authority
IL
Israel
Prior art keywords
bisheterocyclylquinazolines
amino
production
Prior art date
Application number
IL15899802A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL158998A0 publication Critical patent/IL158998A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL15899802A 2001-08-01 2002-07-19 Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines IL158998A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118752.5A GB0118752D0 (en) 2001-08-01 2001-08-01 Process for the production of quinazolines
PCT/IB2002/002872 WO2003011829A1 (en) 2001-08-01 2002-07-19 Process for the production of quinazolines

Publications (1)

Publication Number Publication Date
IL158998A0 true IL158998A0 (en) 2004-05-12

Family

ID=9919612

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15899802A IL158998A0 (en) 2001-08-01 2002-07-19 Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines

Country Status (27)

Country Link
US (1) US7026479B2 (xx)
EP (1) EP1412331B1 (xx)
JP (1) JP2005501054A (xx)
KR (1) KR20040019097A (xx)
CN (1) CN1533378A (xx)
AP (1) AP1299A (xx)
AR (1) AR036204A1 (xx)
AT (1) ATE323677T1 (xx)
BR (1) BR0211670A (xx)
CA (1) CA2451075A1 (xx)
CZ (1) CZ2004151A3 (xx)
DE (1) DE60210778T2 (xx)
DO (1) DOP2002000443A (xx)
EG (1) EG23204A (xx)
ES (1) ES2260457T3 (xx)
GB (1) GB0118752D0 (xx)
HN (1) HN2002000197A (xx)
HU (1) HUP0401573A3 (xx)
IL (1) IL158998A0 (xx)
MX (1) MXPA04000978A (xx)
PA (1) PA8550301A1 (xx)
PE (1) PE20030346A1 (xx)
PL (1) PL368520A1 (xx)
RU (1) RU2261861C1 (xx)
UY (1) UY27399A1 (xx)
WO (1) WO2003011829A1 (xx)
ZA (1) ZA200309043B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1521747B1 (en) * 2002-07-15 2018-09-05 Symphony Evolution, Inc. Receptor-type kinase modulators and methods of use
ATE517091T1 (de) 2003-09-26 2011-08-15 Exelixis Inc C-met-modulatoren und verwendungsverfahren
JP4205757B2 (ja) 2004-05-06 2009-01-07 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー 4−フェニルアミノ−キナゾリン−6−イル−アミド
AR063680A1 (es) * 2006-08-04 2009-02-11 Merz Pharma Gmbh & Co Kgaa Derivados de pirazolo[1, 5-a]pirimidina, metodos e intermediario para su preparacion, composiciones farmaceuticas que los comprenden y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por la modulacion de mglur5.
KR102187034B1 (ko) 2009-01-16 2020-12-04 엑셀리시스, 인코포레이티드 암 치료용 n-(4-{〔6,7-비스(메틸옥시)퀴놀린-4-일〕옥시}페닐)-n'-(4-플루오로페닐)사이클로프로판-1,1-디카르복사미드의 말산염 및 그 결정형
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
IN2012DN00352A (xx) * 2009-06-16 2015-08-21 Bikam Pharmaceuticals Inc
UA108618C2 (uk) 2009-08-07 2015-05-25 Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
US9353063B2 (en) 2011-11-30 2016-05-31 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
RU2593752C1 (ru) * 2012-10-15 2016-08-10 Ресверлоджикс Корп. Соединения, пригодные для синтеза бензамидных соединений
CA2977308A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719378D0 (en) * 1987-08-15 1987-09-23 Pfizer Ltd Antiarrythmic agents
US6069149A (en) * 1997-01-09 2000-05-30 Terumo Kabushiki Kaisha Amide derivatives and intermediates for the synthesis thereof

Also Published As

Publication number Publication date
HUP0401573A2 (hu) 2005-01-28
DOP2002000443A (es) 2003-02-15
EP1412331A1 (en) 2004-04-28
US20030100753A1 (en) 2003-05-29
PA8550301A1 (es) 2003-09-05
AP2002002602A0 (en) 2002-09-30
RU2261861C1 (ru) 2005-10-10
AP1299A (en) 2004-09-06
KR20040019097A (ko) 2004-03-04
EP1412331B1 (en) 2006-04-19
HUP0401573A3 (en) 2005-06-28
ZA200309043B (en) 2004-11-22
GB0118752D0 (en) 2001-09-26
WO2003011829A1 (en) 2003-02-13
AR036204A1 (es) 2004-08-18
UY27399A1 (es) 2003-02-28
DE60210778T2 (de) 2007-01-04
HN2002000197A (es) 2003-02-27
EG23204A (en) 2004-07-31
ES2260457T3 (es) 2006-11-01
RU2004102692A (ru) 2005-07-10
CN1533378A (zh) 2004-09-29
JP2005501054A (ja) 2005-01-13
PL368520A1 (en) 2005-04-04
US7026479B2 (en) 2006-04-11
PE20030346A1 (es) 2003-04-05
DE60210778D1 (de) 2006-05-24
ATE323677T1 (de) 2006-05-15
MXPA04000978A (es) 2004-04-20
CZ2004151A3 (cs) 2005-01-12
BR0211670A (pt) 2004-07-13
CA2451075A1 (en) 2003-02-13

Similar Documents

Publication Publication Date Title
EP1484292A4 (en) GLASS COMPOSITION FOR THE MANUFACTURE OF INORGANIC FIBER, MANUFACTURING METHOD AND PRODUCT MADE OF THE INORGANIC FIBER
HUP0401296A3 (en) Novel processes for producing pyrimidinon derivatives
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
GB2381524B (en) Process for the production of xylitol
GB0114793D0 (en) Hydrogen production process
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
HUP0200567A3 (en) Process for the fermentative production of o-acetyl-serin
EG23439A (en) Olefins production process.
EG23203A (en) Technical process for the manufacture of tropenol.
IL154803A0 (en) New process for the production of oxabispidines
IL159304A0 (en) Process for the production of piperidine derivatives
TWI318975B (en) Process for the production of ethers
MXPA03008022A (es) Proceso para la produccion de polipeptidos.
PL366768A1 (en) Method for the production of improved pulp
AU2002335992A1 (en) Process for the production of ascopyrone p
MXPA03009210A (es) PROCEDIMIENTO PARA LA PREPARACIoN DE OXABISPIDINAS.
IL158119A0 (en) Method for the production of delta1-pyrrolines
EP1553073A4 (en) PROCESS FOR PREPARING 1,2,4-BUTANTRIOL
HUP0401390A3 (en) Process for the manufacture of homopolyamide-4,6 fibers
EG23229A (en) Process for the production of olefins.
EP1457568A4 (en) PROCESS FOR PRODUCING 2'-DESOXYGUANOSINE
IL164437A0 (en) Method for the production of 2,4,5-trimethylphenylacetic acid
AU2002352014A1 (en) Method for the production of organodiphosphonites
AU2003283245A8 (en) Method for the production of 1,6-hexanediol
AU2002240925A1 (en) Process for the production of 6-methylheptanone